Rafferty Asset Management’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.49M | Sell |
|
|||||
|
2025
Q1 | $3.94M | Sell |
|
|||||
|
2024
Q4 | $7.71M | Buy |
|
|||||
|
2024
Q3 | $5.89M | Sell |
|
|||||
|
2024
Q2 | $9.28M | Buy |
|
|||||
|
2024
Q1 | $8.75M | Buy |
|
|||||
|
2023
Q4 | $8.57M | Sell |
|
|||||
|
2023
Q3 | $8.15M | Buy |
|
|||||
|
2023
Q2 | $8.41M | Sell |
|
|||||
|
2023
Q1 | $7.22M | Sell |
|
|||||
|
2022
Q4 | $8.49M | Buy |
|
|||||
|
2022
Q3 | $7.01M | Buy |
|
|||||
|
2022
Q2 | $4.2M | Sell |
|
|||||
|
2022
Q1 | $6.28M | Sell |
|
|||||
|
2021
Q4 | $5.95M | Buy |
|
|||||
|
2021
Q3 | $2.94M | Buy |
|
|||||
|
2021
Q2 | $2.65M | Sell |
|
|||||
|
2021
Q1 | $3.06M | Buy |
|
|||||
|
2020
Q4 | $1.07M | Sell |
|
|||||
|
2020
Q3 | $2.09M | Buy |
|
|||||
|
2020
Q2 | $1.01M | Buy |
|
|||||
|
2020
Q1 | $221K | Sell |
|
|||||
|
2019
Q4 | $2.15M | Buy |
|
|||||
|
2019
Q3 | $1.44M | Sell |
|
|||||
|
2019
Q2 | $1.64M | Buy |
|
|||||
|
2019
Q1 | $533K | Buy |
|